Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAT: Suramin for the Treatment of Autism Trial
NCT06866275Phase 2Recruiting
- Sponsor
- Children's Hospital of Orange County
- Start
- Apr 2025
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of suramin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Children's Hospital of Orange County. Primary endpoint: Vineland Adaptive Behavior Scale Third Edition Socialization Domain at 24 weeks. Started Apr 2025; status: recruiting.
02
Drugs
suramin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT06866275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06866275.